A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug

Inclusion Criteria - All subjects: * Male and females ≥18 years old * Women must be of non-childbearing potential * Adequate hematologic and renal function * BMI 18-35 kg/m2 Inclusion Criteria - Liver Impaired subjects: * Subjects must have stable liver impairment diagnosed with standard classification - Child Pugh Exclusion Criteria - All subjects: * Inability to swallow or absorb oral medication * Uncontrolled medical disorder or infection * Use of CYP3A4 inhibitors/inducers or drugs with risk of Torsades de Pointes * Uncontrolled or Significant cardiovascular disease * Any significant bleeding disorder * Female subjects of childbearing potential * Male subjects unwilling to use an effective method of contraception throughout the conduct of the study and for 2 months thereafter